| Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19 R Yadav, JK Chaudhary, N Jain, PK Chaudhary, S Khanra, P Dhamija, ... Cells 10 (4), 821, 2021 | 434 | 2021 |
| Virtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2 R Yadav, M Imran, P Dhamija, K Suchal, S Handu Journal of Biomolecular Structure and Dynamics 39 (12), 4433-4448, 2021 | 58 | 2021 |
| Preoperative statin therapy is associated with lower requirement of renal replacement therapy in patients undergoing cardiac surgery: a meta-analysis of observational studies I Singh, S Rajagopalan, A Srinivasan, S Achuthan, P Dhamija, D Hota, ... Interactive cardiovascular and thoracic surgery 17 (2), 345-352, 2013 | 50 | 2013 |
| Evaluation of cost of treatment of drug‐related events in a tertiary care public sector hospital in Northern India: a prospective study S Pattanaik, P Dhamija, S Malhotra, N Sharma, P Pandhi British journal of clinical pharmacology 67 (3), 363-369, 2009 | 47 | 2009 |
| Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2 R Yadav, M Imran, P Dhamija, DK Chaurasia, S Handu Journal of Biomolecular Structure and Dynamics 39 (17), 6617-6632, 2021 | 46 | 2021 |
| Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2 R Yadav, S Hasan, S Mahato, I Celik, YS Mary, A Kumar, P Dhamija, ... Journal of molecular liquids 342, 116942, 2021 | 34 | 2021 |
| Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity JK Chaudhary, R Yadav, PK Chaudhary, A Maurya, N Kant, OA Rugaie, ... Cells 10 (11), 2949, 2021 | 34 | 2021 |
| Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis P Dhamija, D Hota, R Kochhar, A Sachdev, A Chakrabarti Indian Journal of Gastroenterology 33, 151-156, 2014 | 27 | 2014 |
| A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence PK Sharma, AK Misra, A Gupta, S Singh, P Dhamija, P Pareek Indian Journal of Pharmacology 50 (5), 273-278, 2018 | 26 | 2018 |
| Patterns of prescription drug use and incidence of drug–drug interactions in patients reporting to medical emergency P Dhamija, D Bansal, A Srinivasan, A Bhalla, D Hota, A Chakrabarti Fundamental & clinical pharmacology 27 (2), 231-237, 2013 | 26 | 2013 |
| Docking of fda approved drugs targeting nsp-16, n-protein and main protease of sars-cov-2 as dual inhibitors R Yadav, RD Parihar, U Dhiman, P Dhamija, SK Upadhyay, M Imran, ... Biointerface Res. Appl. Chem 11 (3), 9848-9861, 2020 | 22 | 2020 |
| Effect of oral administration of crude aqueous extract of garlic on pharmacokinetic parameters of isoniazid and rifampicin in rabbits P Dhamija, S Malhotra, P Pandhi Pharmacology 77 (2), 100-104, 2006 | 22 | 2006 |
| Fetuin-A and vascular calcification in Indian end-stage renal disease population A Mann, V Makkar, S Mann, P Dhamija, P Soundarajan Indian journal of nephrology 26 (1), 33-38, 2016 | 16 | 2016 |
| Only generics (drugs/names): Is India ready? P Dhamija, PK Sharma, S Kalra Indian journal of endocrinology and metabolism 19 (5), 541-545, 2015 | 14 | 2015 |
| Metformin: Midlife maturity, maiden charm S Kalra, P Dhamija, AK Das Indian Journal of Endocrinology and Metabolism 16 (6), 1015-1018, 2012 | 14 | 2012 |
| Package inserts-do they have any role V Bansal, P Dhamija, B Medhi, P Pandhi JK-Practitioner 13 (3), 152-4, 2006 | 12 | 2006 |
| Indian College of Physicians (ICP) Position Statement on Pharmacovigilance YPSB 1. Puneet Dhamija, Sanjay Kalra, Pramod Kumar Sharma, V Kalaiselvan, A ... Journal of The Association of Physicians of India 65, 63-6, 2017 | 11* | 2017 |
| Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets JK Chaudhary, R Yadav, PK Chaudhary, A Maurya, R Roshan, F Azam, ... Cells 10 (9), 2427, 2021 | 9 | 2021 |
| Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others? PK Sharma, S Singh, P Dhamija Indian Journal of Endocrinology and Metabolism 20 (3), 343-347, 2016 | 9 | 2016 |
| Severe cutaneous adverse reactions in Asians: Trends observed in culprit anti-seizure medicines using VigiBase® S Shukla, S Rastogi, SAH Abdi, P Dhamija, V Kumar, V Kalaiselvan, ... Seizure 91, 332-338, 2021 | 7 | 2021 |
Anand SrinivasanAdditional Professor in Pharmacology在 aiimsbhubaneswar.edu.in 的电子邮件经过验证
Anand SrinivasanAdditional Professor in Pharmacology在 aiimsbhubaneswar.edu.in 的电子邮件经过验证
Dipika BansalAssociate Professor, Clinical Research Unit, NIPER, PGIMER在 niper.ac.in 的电子邮件经过验证